Thursday, May 9, 2024

Amyris Closes Ecofabulous Transaction, and Commences Production

Amyris, Inc., a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ operating platform announced that it has closed the acquisition of EcoFabulous, a Gen Z-focused clean beauty consumer brand. Amyris also announced the start of production of a range of consumer products at the Reno, Nevada facility ahead of its mid-year schedule.

Also Read: BioFluidica Announces $6 Million Series B2 Funding to Support of its Liquid Biopsy Microfluidics Platform.

Consistent with its 2022 communicated plan to launch a new Gen-Z clean beauty offering, Amyris has completed the acquisition of EcoFabulous cosmetics. EcoFabulous is a brand dedicated to providing Gen Z consumers affordably priced skin care and color cosmetics with an emphasis on sustainability, product performance and efficacy. Amyris expects sales to begin during the third quarter of 2022 through its direct-to-consumer ecommerce platform and retail partnerships. The acquisition furthers Amyris’ growth and market leadership in clean beauty and complements Amyris’ family of consumer brands.

The transition to the consumer production plant in Reno is an important first step in Amyris’ strategy to consolidate manufacturing capabilities across its growing family of consumer brands. It reduces Amyris’ reliance on third party manufacturing, enhances control over its supply chain and is expected to result in lower unit costs of its consumer products.

“We are very pleased with the addition of EcoFabulous to our family of consumer brands,” said John Melo, President and Chief Executive Officer of Amyris. “Our consumer growth is accelerating due to the early success of our recently launched brands, Rose Inc. and JVN, along with the continued momentum of Biossance, Pipette and Purecane. We have also successfully brought forward production in Reno, Nevada which will support our consumer product growth. The first consumer products will be produced this quarter ahead of our previously communicated mid-year 2022 target. We continue to execute well across our business and expect the first quarter to be our strongest consumer revenue quarter yet.”

About Amyris
Amyris is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company’s proprietary Lab-to-Market™ operating platform. This platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. It’s ingredients are included in over 20,000 products from the world’s top brands, reaching more than 300 million consumers.

Subscribe Now

    Hot Topics